Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Heidi Splete

    News

    FDA approves new formulation of Hyrimoz adalimumab biosimilar

    Author:
    Heidi Splete
    Publish date: March 27, 2023

    The agency approved a higher-concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.

    • Read More

    News

    eNose knows S. aureus in children with cystic fibrosis

    Author:
    Heidi Splete
    Publish date: March 24, 2023

    A cloud-connected electronic nose technology distinguished Staphylococcus aureus with an accuracy of 74%.

    • Read More

    News

    Tyrosine kinase inhibitors – a new weapon against respiratory viruses?

    Author:
    Heidi Splete
    Publish date: March 23, 2023

    In vitro and ex vivo data demonstrated NRTKIs’ ability to slow replication of pandemic and seasonal influenza strains

    • Read More

    News

    Psoriatic arthritis treatment for women falls short, study suggests

    Author:
    Heidi Splete
    Publish date: March 23, 2023

    Women with psoriatic arthritis who were treated with ustekinumab or a tumor necrosis factor inhibitor had lower response rates and persistence at...

    • Read More

    News

    ‘Harm avoidance’ temperament predicts depression in adults

    Author:
    Heidi Splete
    Publish date: March 21, 2023

    Women’s risk of depression also increased with novelty seeking and persistence tendencies.

    • Read More

    News

    Lanolin gets nod for Allergen of the Year

    Author:
    Heidi Splete
    Publish date: March 17, 2023

    Controversy continues over lanolin allergenicity; some patients with positive patch tests can tolerate lanolin ingredients.

    • Read More

    News

    Antioxidants may ease anxiety and depression

    Author:
    Heidi Splete
    Publish date: March 15, 2023

    Antioxidants such as magnesium, zinc, and selenium may have potential as adjunctive treatments.

    • Read More

    News

    Adherence to DASH diet reduced risk of COPD

    Author:
    Heidi Splete
    Publish date: March 14, 2023

    Reduced risk of COPD with the DASH diet persistent in subgroups of men, younger adults, and smokers.

    • Read More

    News

    Gestational diabetes affects fetal lung development

    Author:
    Heidi Splete
    Publish date: March 14, 2023

    Exomes associated with diabetes mellitus impeded the growth and maturation of fetal lungs.

    • Read More

    News

    FDA warns about anaphylaxis after false-negative allergen tests

    Author:
    Heidi Splete
    Publish date: March 14, 2023

    The FDA advises health care professionals to consider confirming a negative skin test with serologic testing for peanut-specific IgE or conducting...

    • Read More

    News

    Yoga linked with improved gait speed, lower extremity strength in older adults

    Author:
    Heidi Splete
    Publish date: March 13, 2023

    New study findings suggest that clinicians can view yoga as part of a strategy to support healthy aging, says author.

    • Read More

    News

    Buprenorphine proves effective for fentanyl users in the ED

    Author:
    Heidi Splete
    Publish date: March 10, 2023

    A new study provides additional information about emergency department buprenorphine as fentanyl becomes increasingly prevalent.

    • Read More

    News

    In utero exposure to asthma medication not tied to risks of neurodevelopmental disorders

    Author:
    Heidi Splete
    Publish date: March 9, 2023

    Data from more than 20,000 children showed no increased risk of autism, ADHD, or Tourette syndrome in children exposed to asthma medication in...

    • Read More

    News

    Cognitive remediation training reduces aggression in schizophrenia

    Author:
    Heidi Splete
    Publish date: March 9, 2023

    Adding social training did not have a significant impact in curbing aggressive behaviors.

    • Read More

    News

    FDA to review dupilumab for treating chronic spontaneous urticaria

    Author:
    Heidi Splete
    Publish date: March 8, 2023

    Dupilumab enters the approval process for adolescents and adults with uncontrolled CSU.

    • Read More

    Pages

    • « first
    • …
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery